Massachusetts Life Sciences Center

The funding is being provided through the Massachusetts Life Sciences Center, which oversees the state's $1 billion life sciences investment plan.

The money from the Massachusetts Life Sciences Center will go toward developing a test that does not require laboratory instrumentation.

NEW YORK (GenomeWeb) – The Massachusetts Life Sciences Center today said that Roche has joined the Center's Corporate Consortium Partners to support early stage life science firms in the state.

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has released the list of firms that will receive a total of $25 million in tax incentives tied to job creation this year, and that list includes several omics and molecular diagnostics firms.

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has provided $8 million in funding to support continued development of the Center for Personalized Cancer Therapy, a joint initiative between the University of Massachusetts Boston and the Dana-Farber/Harvard Cancer Center (DF/HCC

NEW YORK (GenomeWeb News) – Illumina this week declared conformity with the requirements of the IVD Directive and has applied the CE mark for the MiSeqDx Cystic Fibrosis System.

NEW YORK (GenomeWeb News) – The Forsyth Institute plans to use a $4.1 million grant from the Massachusetts Life Sciences Center (MLSC) to create a new center that will develop saliva-based molecular diagnostic tests for assessing disease risk.

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center announced on Wednesday it has awarded Firefly BioWorks a $500,000 matching grant.

Pages

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.